Catridecacog (NovoThirteen)

Status:
Red
Decision Date:
September 2022
 

Comments

RED: Long term prophylaxis of bleeding in patients of all ages with congenital factor XIII A-subunit deficiency and treatment of breakthrough bleeding episodes during regular prophylaxis.

NHS England drug.  To be used in line with NHSE commissioning intentions.

Red Drug Classifications

  • 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app